Evidence map›Paper›PMID 38608822›Full record

ReviewFree radical biology & medicine2024

The therapeutic potential of thiocyanate and hypothiocyanous acid against pulmonary infections.

Nuha Milad Ashtiwi, Susan O Kim, Joshua D Chandler, Balázs Rada

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Free radical biology & medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Factors governing the response ofFrontiers in cellular and infection microbiology · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nuha Milad AshtiwiDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.
Susan O KimPediatrics, Division of Pulmonary, Allergy & Immunology, Cystic Fibrosis, and Sleep Medicine, Emory University, Atlanta, GA, USA.
Joshua D ChandlerPediatrics, Division of Pulmonary, Allergy & Immunology, Cystic Fibrosis, and Sleep Medicine, Emory University, Atlanta, GA, USA; Children's Healthcare of Atlanta, Atlanta, GA, USA.
Balázs RadaDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, USA. Electronic address: radab@uga.edu.
Emory University · USUniversity of Georgia · US

Funding

Dual oxidase and lactoperoxidase in influenza infectionR01AI146857 · NIAID · UNIVERSITY OF GEORGIA · PI RADA, BALAZS, TRIPP, RALPH A · 2020 to 2024
$1.9M
Neutrophil hyperexocytosis and hypochlorous acid exposure in early cystic fibrosis lung diseaseR01HL150658 · NHLBI · EMORY UNIVERSITY · PI Joshua D Chandler · 2023 to 2026
$1.5M
NHLBI NIH HHS R01 HL150658NIAID NIH HHS R01 AI146857
6 · The paper itself

Abstract

Hypothiocyanous acid (HOSCN) is an endogenous oxidant produced by peroxidase oxidation of thiocyanate (SCN

Indexed as

Anti-Infective AgentsThiocyanatesAnimalsAntioxidantsHumansHypochlorous AcidOxidation-ReductionPeroxidaseRespiratory Tract InfectionsAnti-Infective AgentsAntioxidantsHypochlorous Acidhypothiocyanous acidPeroxidasethiocyanateThiocyanatesHypothiocyanous acidInfectionsPeroxidaseRedoxThiocyanate

Identifiers

PMID38608822
PMCPMC11088529
OpenAlexW4394789570

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.